Eeva System
Embryo Image Assessment System, Assisted Reproduction. 510(k) K142147, from Auxogyn, Inc. (Menlo Park, CA). Product code PBH, class 2.
As of Nov 22, 2026, K142147 is an FDA 510(k) held by Auxogyn, Inc., substantially equivalent on Nov 24, 2014 after 111 days, with no recalls tied to it in FDA's recall database.
- Review time: 111 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The Eeva System is indicated to provide adjunctive information on events occurring during the first two days of development that may predict further development to the blastocyst stage on Day 5 of development.
- K120427K120427
- Eeva 2.0DEN120015 · Auxogyn, Inc. · Jun 6, 2014
- Embryo PredictK250781 · Alife Health · May 15, 2026
- KIDScore D3K182798 · Vitrolife A/S · Jul 19, 2019
- Elecsys Progesterone III Cal Check 5K150955 · Roche Diagnostics · May 1, 2015
- Magenta BlastK261736 · Future Fertility, Inc. · Sep 18, 2026
- Embryo PredictK250781 · Alife Health · May 15, 2026
- Chloe BlastK243851 · Fairtility , Ltd. · Aug 15, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 5, 2014
- Review panel
- Obstetrics/Gynecology
- Regulation
- 21 CFR 884.6195
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files